BioSpace News Archive

Genetown

Bayer: How Innovative Farmers Are Tailoring Their Crop Protection

When it comes to raising crops, protecting them through harvest is often the toughest part of the job.

August 24, 2023
·
5 min read
Pharm Country

Ceramedix Awarded Phase 2B NIH SBIR Grant to Evaluate the Non-Clinical Pharmacology of Its Lead Candidate to Support IND Submission

Ceramedix Holding, LLC (Ceramedix) today announced it was awarded a $3,007,043 Phase 2B National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant to evaluate the non-clinical pharmacology of its lead drug candidate.

August 24, 2023
·
3 min read
Pharm Country

MiNK Therapeutics to Participate in September 2023 Investor Conferences

MiNK Therapeutics announced that Dr. Jennifer Buell, Chief Executive Officer and President, will participate in the following upcoming investor conferences.

August 24, 2023
·
1 min read
Ascendis Pharma A/S Announces Three Upcoming September 2023 Investor Presentations

Ascendis Pharma A/S announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in three upcoming investor conferences.

August 24, 2023
·
4 min read
Pharm Country

Verrica Pharmaceuticals Announces First Sale of YCANTH™ to FFF Enterprises

Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the first commercial sale of YCANTH™ to its exclusive distributor, FFF Enterprises Inc. (“FFF”).

August 24, 2023
·
8 min read
Genetown

Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company) today announced that it has developed a novel tablet formulation of IkT-148009, designed to improve drug exposure and overcome existing challenges related to patient use.

August 24, 2023
·
4 min read
Pharm Country

EmpiRx Health Applauds Blue Shield of California for Embracing a Value-based Prescription Drug Model, Announces Four-Point Plan to Accelerate PBM Transformation

EmpiRx Health, the leading value-based PBM company, applauds Blue Shield of California for joining it in implementing a value-based pharmacy care model.

August 24, 2023
·
4 min read
Pharm Country

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at two healthcare industry conferences in September 2023.

August 24, 2023
·
3 min read
Stimlabs® LLC Announces Launch of Relese® - A Uniquely Fenestrated Allograft for Chronic and Acute Wounds

Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds.

August 24, 2023
·
2 min read
FDA

FDA Approves Veklury® (Remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir) with no dose adjustments to treat COVID-19 in people with mild, moderate and severe hepatic impairment.

August 24, 2023
·
11 min read